GlassScriptPhysician profile
Lisa M Deyerle
NPI 1669508735
$7,191.64
in general payments reported to CMS, 2019-2025
36 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $854 · 2020: $972 · 2021: $1,232 · 2022: $1,073 · 2023: $1,630 · 2024: $1,114 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,060.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $851.00 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Abbvie INC. | $813.60 | 2019-2025 | Qulipta, Viberzi, Linzess |
| Novo Nordisk INC | $800.14 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $714.72 | 2019-2025 | |
| Amgen INC. | $470.63 | 2019-2025 | Repatha, Otezla, Evenity |
| Merck Sharp & Dohme LLC | $317.21 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Janssen Pharmaceuticals, INC | $300.85 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $290.90 | 2019-2025 | Trintellix |
| Glaxosmithkline, LLC. | $241.84 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Otsuka America Pharmaceutical, INC. | $234.78 | 2022-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Amarin Pharma, INC. | $169.19 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $169.18 | 2019-2025 | Ajovy |
| Astrazeneca Pharmaceuticals LP | $160.84 | 2019-2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $157.67 | 2019-2022 | |
| Lundbeck LLC | $148.38 | 2022-2025 | Rexulti, Vyepti |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Deyerle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.